The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Leadership - Celgene; Karyopharm Therapeutics; Kite, a Gilead Company
Honoraria - Aptitude Health; Hartley Taylor Medical; Roche
Consulting or Advisory Role - Celgene; Genmab; Karyopharm Therapeutics; Kite, a Gilead Company; Roche
Speakers' Bureau - Aptitude Health; Hartley Taylor Medical; Roche
Research Funding - BeiGene; Blood Cancer UK; Celgene; Genmab; Roche; Roy Castle Lung Cancer Foundation
Travel, Accommodations, Expenses - Celgene; Janssen
First-line treatment (Tx) with subcutaneous (SC) epcoritamab (epco) + R-CHOP in patients (pts) with high-risk diffuse large B-cell lymphoma (DLBCL): Phase 1/2 data update.
 
Lorenzo Falchi
Consulting or Advisory Role - Abbvie; ADC Therapeutics; Genmab; Roche/Genentech
Research Funding - Genmab; Roche
 
Fritz Offner
No Relationships to Disclose
 
David Belada
Consulting or Advisory Role - Debiopharm Group; Gilead Sciences; Janssen-Cilag; MorphoSys; Roche; Takeda
Research Funding - Dr. Reddy's (Inst); Genmab (Inst); Gilead Sciences (Inst); Janssen-Cilag (Inst); MorphoSys (Inst); Pharmacyclics (Inst); Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Roche; Takeda
 
Joshua Brody
No Relationships to Disclose
 
Kim M. Linton
No Relationships to Disclose
 
Yasmin Karimi
No Relationships to Disclose
 
Raul Cordoba
Consulting or Advisory Role - Celgene/Bristol-Myers Squibb; Incyte; Janssen; Kite/Gilead; Kyowa-Kirin; Takeda
Speakers' Bureau - Abbvie; AstraZeneca; Roche
Research Funding - Pfizer
Travel, Accommodations, Expenses - Abbvie; Janssen; Roche
 
Sylvia Snauwaert
No Relationships to Disclose
 
Aqeel Abbas
Employment - Genmab
 
Liwei Wang
Employment - Genmab
 
Jun Wu
Employment - Abbvie
 
Brian Elliott
Employment - Genmab; Novartis
Stock and Other Ownership Interests - Genmab; Novartis
Patents, Royalties, Other Intellectual Property - Patents pending related to Genmab development of epcoritamab
Travel, Accommodations, Expenses - Genmab; Novartis
 
Michael Roost Clausen
Leadership - Abbvie; Janssen
Honoraria - Abbvie; Janssen
Consulting or Advisory Role - Abbvie; Gilead Sciences; Janssen
Travel, Accommodations, Expenses - Abbvie; Gilead Sciences